Delivering enhanced technology that improves productivity, efficiency and quality We are excited to announce that the latest version of Opcenter…
Using digital collaboration to achieve productivity and delivery goals When manufacturers are asked to characterize their supply chain today, resilient…
Simplifying the Process Instruction program rollout We are excited to announce that the latest version Opcenter™ Execution Pharma v. 2205…
Delivering an enhanced RESTful API for improved productivity, efficiency and quality We are excited to announce that the latest version…
Supporting greater collaboration and improving operational efficiency We are excited to announce that the latest version of Opcenter Execution Medical…
Providing a paperless solution for the life sciences/pharma industries! We are excited to announce that the latest version Opcenter™ Execution…
The New Regulation (EU) 2017/745 for medical devices (MDRs), which went into effect on May 26, 2021, is a major update to the regulatory framework in the European Union (EU).
Today’s disruptive market scenarios, the unknown consequences of COVID-19, increasingly sophisticated personalized, and the new FDA and EU Regulatory implications…
The COVID-19 pandemic has disrupted global supply chains on a monumental scale, rushing all MD&D manufacturers to quickly re-adapt and respond to new challenging market scenarios.
